Latest Market News

Peak Rare Earths made significant strides in the March 2025 quarter, progressing its Ngualla Rare Earth Project, securing A$8.5 million in capital, and benefiting from a surge in rare earth prices driven by growing EV demand and evolving Chinese regulations.

Bio-Gene Technology Limited has been awarded two significant grants totaling A$3 million by the US Department of Defense, validating its innovative insecticide technologies Flavocide® and Qcide®. The company is advancing regulatory filings and scaling production to target both military and civilian markets.

First Graphene Limited reported a successful A$2.4 million capital raise alongside promising progress in its PureGRAPH-CEM product trials in the UK and South Africa, while securing key patents and expanding distribution across Asia and South America.

Piedmont Lithium reported a 15% decline in Q1 2025 spodumene concentrate production due to weather disruptions, yet achieved a record lithium recovery rate in March, signaling operational resilience amid challenges.

WhiteHawk Limited reported solid Q1 2025 progress with a $2.4 million contract renewal and a landmark $920 million subcontract on a U.S. federal government vehicle, alongside multiple new cyber risk program wins.

RTG Mining has locked in a US$30 million financing facility with Glencore to fund the initial stage of its high-grade Mabilo Copper and Gold Project in the Philippines, while advancing exploration and development at its Chanach and Panguna projects.

Argenica Therapeutics has completed patient dosing in its Phase 2 trial of ARG-007 for acute ischaemic stroke, with topline data expected in Q3 2025. The company also plans to submit its Investigational New Drug application and Fast Track request to the FDA imminently.

Firebird Metals has made significant strides in its LMFP battery strategy, finalizing multiple offtake agreements with Chinese manufacturers and securing a mining lease for its Oakover project, positioning itself as a low-cost producer in the growing battery materials market.

EMVision Medical Devices has commenced the pivotal clinical trial for its emu™ bedside brain scanner aimed at FDA clearance, while advancing its First Responder device through successful aeromedical testing and ethics approvals. The company maintains strong cash reserves of $12.58 million to support ongoing innovation and clinical activities.

Rent.com.au Limited reported a net cash outflow of $497k in Q3 FY25 but secured a $1.7 million capital injection through a fully-underwritten entitlement issue to support ongoing operations.

Universal Biosensors reported a 28% increase in customer receipts to $1.6 million for Q1 2025, alongside improved cash flow and plans for a new product launch later this year.

Perseus Mining Limited delivered a robust March 2025 quarter with steady gold production, strong cash flow, and key project milestones including FIDs for the CMA Underground and Nyanzaga Gold projects.